Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.
We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.
As a leader in the field of precision oncology treatments and theranostics it is our goal to support critical advancements in our field, foster dialogue, and work together to bring precision medicine to the patients that need it. That is why we are very excited that key members of our Board are highly committed to this mission too, bringing to life an important industry event the International Centers for Precision Oncology (ICPO) Forum for Theranostics in Precision Oncology.
This week, we had the pleasure to support the 2nd ICPO Forum for Theranostics in the field of Precision Oncology. The hybrid event took place right in the heart of the Research Campus in Garching / Munich next to one of the few reactors used to produce medical radioisotopes worldwide as well as the ITM headquarters. In addition to participating in the event we also had the opportunity to present ITM at the conference highlighting our efforts to bring Targeted Radionuclide Therapies and theranostics to cancer patients globally.
Due to the high demand for the Forum, registration for on-demand streaming of the ICPO-Forum presentations is still open until December 31st. For registered participants networking is possible until October 26, 2021.
More information on the ICPO Foundation, its mission and the Forum can be found on the ICPO website.